Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $84.4600 (-1.39%) ($81.1300 - $86.7000) on Thu. Oct. 1, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.65% (three month average) | RSI | 38 | Latest Price | $84.4600(-1.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2.9% a day on average for past five trading days. | Weekly Trend | LGND declines -6.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) XBI(58%) IWO(56%) ARKG(52%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.825% in a week (0% probabilities). VIXM(-18%) TLT(-15%) UUP(-6%) IGOV(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.825% (StdDev 3.65%) | Hourly BBV | 0 () | Intraday Trend | -1.2% | | | |
|
1 - 5 Day Possible Target | $75.78(-10.28%) | Resistance Level | $92.98 | 5 Day Moving Average | $85.27(-0.95%) | 10 Day Moving Average | $91.42(-7.61%) | 20 Day Moving Average | $92.98(-9.16%) | To recent high | -17.1% | To recent low | 2.9% | Market Cap | $1.357b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |